Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
The Clinical Picture

Fixed drug eruption due to ibuprofen

Aneri Patel, BS, Ilana D. Breen, MD, Joshua M. Schulman, MD and Apra Sood, MD
Cleveland Clinic Journal of Medicine October 2024, 91 (10) 597-598; DOI: https://doi.org/10.3949/ccjm.91a.24012
Aneri Patel
Department of Dermatology, University of California, Davis, Sacramento, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ilana D. Breen
Department of Dermatology, University of California, Davis, Sacramento, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joshua M. Schulman
UC Davis School of Medicine, Davis, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Apra Sood
Department of Dermatology, University of California, Davis, Sacramento, CA; Department of Dermatology, VA Northern California Health Care, Mather, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

A 76-year-old man with a history of lumbar radiculopathy and chronic low back pain presented with a 2-month history of a lesion on the left groin that caused a burning sensation. He had been taking 600 to 1,200 mg ibuprofen daily for back pain for more than 1 year. His other medications included gabapentin 400 mg for sleep and a daily multivitamin.

Physical examination revealed a well-demarcated violaceous 8-cm plaque with perilesional erythema on the left inguinal fold (Figure 1). A 4-mm punch biopsy of the skin revealed a vacuolar interface dermatitis with numerous eosinophils and melanophages. The clinical and histopathologic features combined with the patient’s medication history supported a diagnosis of fixed drug eruption due to ibuprofen.

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

An 8-cm violaceous plaque with surrounding mild erythema in the patient’s left inguinal fold.

The ibuprofen was discontinued and replaced with acetaminophen. The patient was prescribed a medium-strength topical steroid for symptomatic management. The skin lesion resolved over 3 weeks and has not recurred.

FIXED DRUG ERUPTION

The well-demarcated violaceous plaque on the groin in this patient raised suspicion for a variety of lesions, including an insect bite, bullous pemphigoid, bullous fixed drug eruption, erythema multiforme, leukocytoclastic vasculitis, lichen planus, large plaque parapsoriasis, and sarcoidosis (Table 1).1,2 Of these diagnoses, the rapid onset of a solitary plaque with symptoms of burning following a recent medication exposure was most suggestive of fixed drug eruption, a relatively uncommon cutaneous reaction to medication.3

View this table:
  • View inline
  • View popup
TABLE 1

Differential diagnosis of fixed drug eruption and differentiating features

Fixed drug eruption lesions usually present as 1 or more circular patches with a violaceous hue on any part of the trunk or extremities. Mucosal and genital lesions may also occur.3 This reaction typically recurs in the same site on reexposure to the causative medication. Although the lesions are mostly asymptomatic, there may be mild pruritus, burning, or stinging.

A history of recent medication exposures, including over-the-counter agents, is a clue to the diagnosis.1,3 Fixed drug eruptions are associated with many drugs, especially antibiotics (eg, trimethoprim-sulfamethoxazole, tetracyclines, penicillin), nonsteroidal anti-inflammatory drugs such as ibuprofen or naproxen, antifungals, antihistamines, and acetaminophen; less common associations include carbamazepine and allopurinol.1,3,4,5

Workup for a suspected fixed drug eruption, including the need for laboratory evaluation and biopsy, varies based on the clinical examination and history. Because the diagnosis of fixed drug eruption is largely clinical, primary care clinicians should maintain a low threshold for referral to dermatology if there is diagnostic uncertainty or lack of supportive history.2

Management includes discontinuation of the drug, and the prognosis is good, with the lesion(s) usually resolving without treatment. For symptomatic relief, medium-to-high potency topical corticosteroids can be prescribed.2 A short course of systemic corticosteroids may be needed for multiple lesions.1

Because these lesions are uncommon, they are often overlooked or misdiagnosed. Early diagnosis can prevent long-term complications such as rare generalized bullous lesions or postinflammatory hyperpigmentation.

DISCLOSURES

The authors report no relevant financial relationships which, in the context of their contributions, could be perceived as a potential conflict of interest.

  • Copyright © 2024 The Cleveland Clinic Foundation. All Rights Reserved.

REFERENCES

  1. ↵
    1. Anderson HJ,
    2. Lee JB
    . A review of fixed drug eruption with a special focus on generalized bullous fixed drug eruption. Medicina (Kaunas) 2021; 57(9):925. doi:10.3390/medicina57090925
    OpenUrlCrossRef
  2. ↵
    1. Weyers W,
    2. Metze D
    . Histopathology of drug eruptions—general criteria, common patterns, and differential diagnosis. Dermatol Pract Concept 2011; 1(1):33–47. doi:10.5826/dpc.0101a09
    OpenUrlCrossRefPubMed
  3. ↵
    1. Shaker G,
    2. Mehendale T,
    3. De La Rosa C
    . Fixed drug eruption: An under-recognized cutaneous manifestation of a drug reaction in the primary care setting. Cureus 2022; 14(8):e28299. doi:10.7759/cureus.28299
    OpenUrlCrossRef
  4. ↵
    1. Jhaj R,
    2. Chaudhary D,
    3. Asati D,
    4. Sadasivam B
    . Fixed-drug eruptions: what can we learn from a case series?. Indian J Dermatol 2018; 63(4):332–337. doi:10.4103/ijd.IJD_481_17
    OpenUrlCrossRefPubMed
  5. ↵
    1. Kim MH,
    2. Shim EJ,
    3. Jung JW,
    4. Sohn SW,
    5. Kang HR
    . A case of allopurinol-induced fixed drug eruption confirmed with a lymphocyte transformation test. Allergy Asthma Immunol Res 2012; 4(5): 309–310. doi:10.4168/aair.2012.4.5.309
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 91 (10)
Cleveland Clinic Journal of Medicine
Vol. 91, Issue 10
1 Oct 2024
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Fixed drug eruption due to ibuprofen
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Fixed drug eruption due to ibuprofen
Aneri Patel, Ilana D. Breen, Joshua M. Schulman, Apra Sood
Cleveland Clinic Journal of Medicine Oct 2024, 91 (10) 597-598; DOI: 10.3949/ccjm.91a.24012

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Fixed drug eruption due to ibuprofen
Aneri Patel, Ilana D. Breen, Joshua M. Schulman, Apra Sood
Cleveland Clinic Journal of Medicine Oct 2024, 91 (10) 597-598; DOI: 10.3949/ccjm.91a.24012
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • FIXED DRUG ERUPTION
    • DISCLOSURES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Tinea incognito
  • Prolonged venous filling time and dependent rubor in a patient with peripheral artery disease
  • Sarcoidosis with diffuse purplish erythematous plaques on the hands
Show more The Clinical Picture

Similar Articles

Subjects

  • Dermatology
  • Physical Exam

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire